Anti-cardiolipin and increased serum adhesion molecule levels in patients with aggressive periodontitis

Journal of Periodontology

Volumn 78, Issue 3, 2007, Pages 459-466

  Schenkein, Harvey A ^a   Best, Al M ^b   Brooks, Carol N ^a   Burmeister, John A ^a   Arrowood, James A ^b   Kontos, Michael C ^b   Tew, John G ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticardiolipin; Cell adhesion; Inflammation; Markers; Periodontitis; Proteins

Indexed keywords

BIOLOGICAL MARKER; CARDIOLIPIN ANTIBODY; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PERIODONTITIS; REGRESSION ANALYSIS; VASCULITIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; E-SELECTIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PERIODONTITIS; REGRESSION ANALYSIS; VASCULAR CELL ADHESION MOLECULE-1; VASCULITIS;

EID: 33947677616     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.060305     Document Type: Article

References (41)

1. Schenkein HA, Berry CR, Burmeister JA, et al. Anticardiolipin antibodies in sera from patients with periodontitis. J Dent Res 2003;82:919-922.
2. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000;15:145-151.
3. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763.
4. Marai I, Gilburd B, Blank M, Shoenfeld Y. Anticardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome. Hum Antibodies 2003;12:57-62.
5. Sorice M, Pittoni V, Griggi T, et al. Specificity of antiphospholipid antibodies in infectious mononucleosis: A role for anti-cofactor protein antibodies. Clin Exp Immunol 2000; 120:301-306.
6. Dalekos GN, Zachou K, Liaskos C. The antiphospholipid syndrome and infection. Curr Rheumatol Rep 2001;3:277-285.
7. Guglielmone H, Vitozzi S, Elbarcha O, Fernandez E. Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections. Ann Rheum Dis 2001;60:500-504.
8. Ordi-Ros J, Villarreal J, Monegal F, et al. Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: Characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol 2000;7:241-244.
9. Uthman IW, Gharavi AE. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 2002;31:256-263.
10. Hojnik M, Gilburd B, Ziporen L, et al. Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: Analysis of anticardiolipin antibodies in leprosy. Lupus 1994;3: 515-521.
11. Gharavi AE, Pierangeli SS, Harris EN. Origin of antiphospholipid antibodies. Rheum Dis Clin North Am 2001;27:551-563.
12. Pierangeli SS, Colden-Stanfield M, Liu X, et al. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999;99:1997-2002.
13. Kaplanski G, Cacoub P, Farnarier C, et al. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: Correlations with the severity of thrombosis. Arthritis Rheum 2000;43:55-64.
14. Pierangeli SS, Espinola RG, Liu X, Harris EN. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res 2001;88:245-250.
15. Pierangeli SS, Harris EN. Probing antiphospholipid-mediated thrombosis: The interplay between anticardiolipin antibodies and endothelial cells. Lupus 2003;12:539-545.
16. Williams FM, Parmar K, Hughes GR, Hunt BJ. Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemost 2000;84:742-746.
17. Ferro D, Pittoni V, Quintarelli C, et al. Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic state. Circulation 1997;95:1425-1432.
18. Espinola RG, Liu X, Colden-Stanfield M, et al. E-Selectin mediates pathogenic effects of antiphospholipid antibodies. J Thromb Haemost 2003;1:843-848.
19. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
20. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21:533-551.
21. Muhlemann HR, Son S. Gingival sulcus bleeding: A leading symptom in initial gingivitis, Helv Odontol Acta 1971;15:107-113.
22. Singh S, Cianciola L, Genco RJ. The suppurative index: An indicator of active periodontal disease. J Dent Res 1977;56:B200(Abstr. 593).
23. Schenkein HA, Van Dyke TE. Early-onset periodontitis: Systemic aspects of etiology and pathogenesis. Periodontol 2000 1994;6:7-25.
24. Salzberg TN, Overstreet BT, Rogers JD, et al. C-reactive protein levels in patients with aggressive periodontitis. J Periodontol 2006;77:933-939.
25. Blank M, Krause I, Fridkin M, et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002;109:797-804.
26. Palmer RM, Stapleton JA, Sutherland G, et al. Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM-1, sCD44v5, sCD44v6). Eur J Clin Invest 2002;32:852-857.
27. Keaney JF Jr., Massaro JM, Larson MG, et al. Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study. J Am Coll Cardiol 2004;44:168-173.
28. Lain KY, Luppi P, McGonigal S, Roberts JM, Deloia JA. Intracellular adhesion molecule concentrations in women who smoke during pregnancy. Obstet Gynecol 2006; 107:588-594.
29. Blann AD, Seigneur M, Steiner M, Miller JP, McCollum CN. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: Relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb Haemost 1998;79:1080-1085.
30. Mizia-Stec K, Zahorska-Markiewicz B, Gasior Z. Cigarette smoking and inflammatory indices in coronary artery disease. Int J Cardiol 2004;93:169-174.
31. Fickl H, Van Antwerpen VL, Richards GA, et al. Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers. Atherosclerosis 1996;124:75-81.
32. Glurich I, Grossi S, Albini B, et al. Systemic inflammation in cardiovascular and periodontal disease: Comparative study. Clin Diagn Lab Immunol 2002;9:425-432.
33. Miller MA, Sagnella GA, Kerry SM, et al. Ethnic differences in circulating soluble adhesion molecules: The Wandsworth Heart and Stroke Study. Clin Sci (Lond) 2003;104:591-598.
34. Cho CS, Cho ML, Chen PP, et al. Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells. J Immunol 2002;168:4209-4215.
35. Faber-Elmann A, Sthoeger Z, Tcherniack A, Dayan M, Mozes E. Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus. Clin Exp Immunol 2002; 127:393-398.
36. Ferro D, Pignatelli P, Loffredo L, et al. Soluble CD154 plasma levels in patients with systemic lupus erythematosus: Modulation by antiphospholipid antibodies. Arthritis Rheum 2004;50:1693-1694.
37. George J, Blank M, Levy Y, et al. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 1998;97:900-906.
38. Kornberg A, Blank M, Kaufman S, Shoenfeld Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol 1994;153:1328-1332.
39. Mo L, Salmon JE. Intercellular adhesion molecule 1 expression is required for antiphospholipid antibody-induced pregnancy loss. Arthritis Rheum 2001;44:1225-1226.
40. Simantov R, Lo SK, Gharavi A, et al. Antiphospholipid antibodies activate vascular endothelial cells. Lupus 1996;5:440-441.
41. Lopez-Pedrera C, Buendia P, Barbarroja N, et al. Antiphospholipid-mediated thrombosis: Interplay between anticardiolipin antibodies and vascular cells. Clin Appl Thromb Hemost 2006; 12:41-45.